479 A lymph-node targeted amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2

• Martin Steinbuck,
• Peter DeMuth,
• Lochana Seenappa,
• Christopher Haqq,
• Aniela Jakubowski,
• Lisa McNeil

Affiliations

Martin Steinbuck

Elicio Therapeutics, Boston, MA, USA

Peter DeMuth

Elicio Therapeutics, Boston, MA, USA

Lochana Seenappa

Elicio Therapeutics, Boston, MA, USA

Christopher Haqq

Elicio Therapeutics, Boston, MA, USA

Aniela Jakubowski

Elicio Therapeutics, Boston, MA, USA

Lisa McNeil

Elicio Therapeutics, Boston, MA, USA